Regulation

FDA QMSR / 21 CFR Part 820

QMSR: 2024 final rule · Final / published
United States · Medical devices

Finished medical-device manufacturers and the operations within Part 820 scope.

Does this apply to my work?

Check the manufacturer, device and operations against § 820.1. ISO certification alone does not establish conformity with all FDA requirements.

Effective 2 February 2026.

What does it address?

Part 820 establishes the quality-system framework and incorporates ISO 13485:2016, subject to FDA provisions.

What does this mean in practice?

The controls and evidence below are practitioner examples. They are not mandatory document names or a complete list of obligations.

Practical interpretation of FDA QMSR / 21 CFR Part 820
Source provision	Requirement or recommendation	Practical control or activity	Example evidence	Applicability note
§§ 820.7 and 820.10	Regulatory requirement within scope	Identify applicable incorporated QMS requirements and FDA-specific provisions.	Process assessment and controlled evidence of implementation.	Use the incorporated edition and the applicable FDA text.

Illustrative example

A decision in practice

Intended use: A device manufacturer uses software to control material disposition.
Risk: An incorrect status could permit use of nonconforming material.
Control: Define disposition authority and block unauthorized status changes.
Testing: Challenge role permissions and attempts to issue held material.
Evidence: Approved process scope, test observations and disposition records.
Conclusion: The illustrative team considers both the QMS process and the configured software evidence before authorizing use.

More practitioner context

Practical impact

Connect computerized-system validation evidence to the QMS process supported and review procedures, references, supplier controls, and inspection records for QMSR alignment.

Actions to consider

Use the current rule and FDA implementation material to complete a documented, process-specific assessment.

Practitioner interpretation

Do not treat QMSR implementation as a terminology-only update. Determine which QMS processes, records, and software controls are affected.

Continuing context

Manufacturers remain responsible for applicable FD&C Act and FDA requirements. A certificate or generic standards claim does not establish software fitness for a particular use.

Source and review information

Source check: 21 September 2026. Publication identity, scope and status checked against the linked official source. This is not an independent audit of every retained guide statement.

Citation, dates and editorial history

Stable source ID: fda-quality-management-system-regulation
Official citation: 21 CFR Part 820 — Quality Management System Regulation
Issuing organization: U.S. Food and Drug Administration
Edition: QMSR: 2024 final rule
Publication: 2 February 2024
Application / transition: Effective 2 February 2026.
Publication status: Final / published
Verification: Verified — public source metadata and scope
Editorial update: 21 September 2026 · Version 2.0
Source owner: CSVtoCSA editorial
Review needed: Recheck when the source or intended use changes
Independent review: No independent regulatory review is claimed.
Earlier publication: Pre-2 February 2026 Quality System Regulation text; use the eCFR historical timeline for historical citations.
Prior editorial date: 12 September 2026 (existing record or detailed guide)
Additional retained source: Original source link

21 September 2026: Source metadata checked, scope clarified, practical mapping and illustrative example added, and layout reorganized. Existing detailed guide content and its dated history are retained below its disclosure. This is an editorial update, not a regulatory amendment.

Questions and corrections

Contributor opinions are moderated and remain distinct from the source and site explanation. Comments do not update source metadata.

Suggest a source correction

Sent privately to the editorial moderation queue. Your account email and correction are not published as a comment. Do not include confidential or personal information.

Source: fda-quality-management-system-regulation

Loading sign-in status…

Ask a question or share a professional example

Questions and discussion

Ask a question or share a perspective. Contributions are reviewed before publication.

Loading contribution options…